Labiotech.eu

Ever heard of these six companies in the TIL therapies space? 👂 Tumor-infiltrating lymphocyte or TIL therapy is a kind of cell therapy that uses a patient’s own cells to fight cancers. 🥊 ✅ The only TIL therapy that has been approved so far is Iovance Biotherapeutics, Inc.’ Amtagvi for melanoma in the U.S. and Australia.  🏥 But there are various biotechs developing TILs in clinical trials at present. Labiotech has created a list of six companies with promising candidates for solid tumors.  Read our latest article to find out. 👇  https://lnkd.in/dDRrBRU7  #celltherapy #cancerresearch #immunotherapy #oncology #biotech #precisionmedicine #melanoma #lifesciences #innovation  CuraCell Obsidian Therapeutics KSQ Therapeutics, Inc. AgonOx, Inc. Grit Biotechnology

CGT scale-up across sites, assays, and teams. As CGT manufacturing expands, consistency becomes a practical challenge. But scaling is not only about doing more, it is about keeping clinical workflows reliable across sites, assays, and teams. 🧬    📖 These case-studies look at real-world examples across CGT operations: One automated, closed T cell manufacturing workflow transferred across three GMP sites with consistent performance. Early analytical alignment and standardized flow cytometry workflows for QC readiness. Structured operator training to support consistent performance during scale-up.   📥 Access the case studies https://lnkd.in/dU7z5SdC   #CellAndGeneTherapy #CGT #CellTherapyManufacturing #QualityControl #Biopharma Miltenyi Biotec

Munich has long been recognized as one of Germany's scientific powerhouses, but in recent years it has also emerged as one of Europe's most dynamic biotech and life sciences ecosystems. 🧬🇩🇪 Bringing together leading academic institutions, multinational pharmaceutical companies, cutting-edge startups, and strong investment, the region has created an environment that consistently translates scientific research into commercial innovation. 🚀🔬 Read our latest article by Willow Shah-Neville, as we take a closer look at the factors driving the success of Munich’s burgeoning biotech hub! 👇  https://lnkd.in/d7wjvpWr  #biotech #lifesciences #biotechnology #innovation #science #medtech Ralf Huss BioM Biotech Cluster Development GmbH

Epidermolysis bullosa, or EB, is one of those diseases that stops you in your tracks the moment you understand it. 🖐🏻 🩹 Skin so fragile that the gentlest touch can cause blisters and open wounds. No cure. And for most of its history, very little serious drug development attention.  But one non-profit is on a mission to make EB curable. 🎯 💰 By funding research, building shared infrastructure, and connecting the right people at the right time, DEBRA Research has a growing portfolio of investments and a seat at the table in deals that are moving the needle for patients who have waited long enough. 🎙️ On the latest episode of the Beyond Biotech Podcast, Labiotech’s Dylan Kissane sat down with DEBRA Research’s Managing Director Martin Steiner to discuss the company’s role in the drug development ecosystem, the promising approaches to treat EB, and how to overcome obstacles and enable collaboration in rare disease. 🤝 🎧 Tune in to our latest episode to learn more. 👇  https://lnkd.in/dqtAe296    #BeyondBiotechPodcast #epidermolysisbullosa #raredisease #drugdevelopment #biotech #lifesciences #healthcareinnovation 

What if adopting a new technology started with validating your workflow instead of buying new equipment? 🔬 Europe's life sciences ecosystem is becoming increasingly collaborative, and Customer Experience Centers are reflecting it. They give researchers, clinicians, and industry partners the opportunity to evaluate technologies in realistic laboratory settings and refine workflows before large-scale implementation. MGI is contributing to this approach with its Berlin Customer Experience Center, designed as an open environment where users can explore applications, exchange expertise, and validate solutions for their own research. ⬇️  https://lnkd.in/djpDpZzK  #genomics #multiomics #lifesciences #precisionmedicine #scientificinnovation 

mRNA biotechs: Seven companies leading the way.

How is HIV research holding up? 🔎   HIV research has come a long way since the virus was discovered in the 1980s. Antiretroviral therapy (ART) marked a turning point in HIV treatment, changing the lives of millions. 💡    With the approval of twice-yearly lenacapavir for HIV prevention in June 2025, scientific progress has continued even as abrupt cuts and restructuring of U.S. foreign assistance have disrupted HIV services in many of the countries most dependent on international support. 💸 Read more below 👇   https://lnkd.in/dBRh8hqa  #HIV #HIVresearch #HIVprevention #globalhealth #publichealth #medicalresearch #healthequity

The approach to sequencing genetic material has evolved over the decades. 🌱 When next generation sequencing arrived in the market at the beginning of this century, it replaced the slow and expensive Sanger sequencing, allowing several DNA fragments to be read simultaneously. 🧬 Much of the world’s NGS has been performed by Illumina, which has historically produced about 90% of the world’s genomic data. Various sequencers have attempted to topple Illumina’s dominance, but Illumina continues to lead the genomic sequencing space. 🥇 Now with the entry of Roche’s AXELIOS 1, could this break Illumina’s long-standing hold over the market? 🛒 Read our latest article to find out. 👇 https://lnkd.in/eCt2q6kP   Oxford Nanopore Technologies, PacBio, Element Biosciences #NGS #nextgenerationsequencing #DNA #biotech #biopharma #genomic

What makes a biotech hub more than just laboratory space? 🧬 For many companies, success depends as much on the surrounding ecosystem as the facilities themselves. Access to scientific expertise, GMP capabilities, skilled talent, and opportunities to collaborate can all influence how quickly programs move from research to development. Marburg has been building exactly that kind of environment. Through the M600 campus, CSL is opening a purpose-built R&D site designed to connect startups, CROs, CDMOs, academia, and biopharma companies within one integrated life sciences ecosystem. Discover why Marburg is emerging as a strategic biotech location. ⬇️ https://lnkd.in/e7d-NjtU #Biotech #Lifesciences #CSL #Marburg #Biotechhub #GMP #Drugdevelopment

Is Guinea worm getting closer to eradication?💉 In 2025, just 10 people worldwide were diagnosed with Guinea worm disease. Four decades earlier, the parasitic infection afflicted an estimated 3.5 million people every year across 21 countries in Africa and Asia. This decline has brought Guinea worm closer than ever to becoming the second human disease in history to be eradicated.🎯 Despite centuries of medical progress, the world has only eradicated smallpox. Polio has remained close for decades, while diseases such as malaria and measles continue to circulate despite effective tools to control them. So why do some diseases disappear while others persist? 👇 https://lnkd.in/eZYQuBmA #Biotech #Globalhealth #Infectiousdisease #Drugdevelopment #Lifesciences